Issue 51 of Skin 'n' Bones Connection is now available. A digital version is also available FREE to subscribing members.

Do you have 5 minutes to change psoriatic arthritis? Have your say and be part of the debate on psoriatic arthritis research.

Rheumatology research doctors from University College London Hospital have developed a survey for people with psoriatic arthritis...

An estimated 60 million people worldwide have the chronic skin condition, psoriasis, according to the latest results of the Global Psoriasis Atlas (GPA).

The availability of testing for COVID-19 has been widened to include groups beyond NHS frontline staff.

The Commission of Human Medicines (CHM)Expert Working Group on coronavirus (COVID-19) has concluded that there is currently insufficient evidence to establish a link between use of ibuprofen, or other non-steroidal anti-inflammatory drugs (NSAIDs), and susceptibility to contracting COVID-19 or the worsening of its symptoms.

New guidelines issued by NICE to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. 

PsoProtect is an international registry for health care providers to report outcomes of COVID-19 in individuals with psoriasis.

We are working remotely to abide and support the current Government instructions, but we will continue to provide the services you require, although under these uncertain times, restrictions may mean it takes us a little longer to deal with your needs and enquiries.

If you have either psoriasis and/or psoriatic arthritis and are worried about the Coronavirus (COVID-19) and how it may affect you, go to the NHS website or the UK official government website.